Efficacy of Convulsive Therapies for Bipolar Depression (CORRECT-BD)
Cognitive Outcomes and Response/Remission Efficacy of Convulsive Therapies for Bipolar Depression: the CORRECT-BD Trial
Sponsor: Brain Canada
Listed as NCT03641300, this NA trial focuses on Bipolar Depression and Bipolar Disorder and remains completed. Sponsored by Brain Canada, it has been updated 12 times since 2018, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
12 versions recorded-
Dec 2024 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2023 — Apr 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Mar 2023 — May 2023 [monthly]
Recruiting NA
-
Sep 2021 — Mar 2023 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2020 — Jun 2020 [monthly]
Recruiting NA
-
Nov 2018 — Jan 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brain Canada
- Centre for Addiction and Mental Health
- Ontario Shores Centre for Mental Health Sciences
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .